|Articles|January 12, 2021
- Pharmaceutical Executive-01-01-2021
- Volume 41
- Issue 1
Pharmaceutical Executive, January 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive January 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 5 years ago
2021 in Focus: Pharm Exec’s Annual Industry Outlookalmost 5 years ago
‘Breakthrough’ Balancing Act: The Decline of the Value Propositionalmost 5 years ago
Prescriber Hesitancy on COVID Vaccinesalmost 5 years ago
More Cloud on the Horizon for Pharmaalmost 5 years ago
A New Year for Sustainable Governancealmost 5 years ago
Bound By Bloodalmost 5 years ago
Pharma in Spotlight as Pandemic Continues in 2021almost 5 years ago
Six Degrees of 2020almost 5 years ago
Why Investing in Tech Education Is Importantalmost 5 years ago
Pharm Exec Hits 40Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
4
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
5
